|  | 
|  |  | 
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. | 
|   
 
    
    
    
NCDP NICODROPS (Other OTC:NCDP.PK)  Worth a look, as this is a small co that has recently had major news - and looks on track to be a Major player in the stop-smoking market... Nicodrops, Inc. developer of the world's first drug-free, non-nicotine smoking cessation lozenge, announced today it has formally received approval from the Canadian Food and Drug Administration for their smoking cessation lozenge. The Canadian FDA Approval Drug Identification Number (DIN) 00245097 was issued through the Therapeutic Products Directorate of the Health Canada, FDA. The DIN number now permits Nicodrops to sell its products in the Canadian market. the potential market for this product is over a Billion US $ In 1999, SmithKline Beecham Consumer Healthcare's combined U.S. sales of Nicorette and NicoDerm CQ reached $570 million. The 1999 [Philippe Boucher's Rendez-vous with Leslie Ashburn, Communications Supervisor for GlaxoSmithKline, 1/29/01]. and that's just from one company :-) doing biz in US. Unfortionately this stock is nominated for "Stock Dump of 2004" Biggest Dumpers Award. | ||||||||||||||
| 
 
 | 
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings | 
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI | 
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |